These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome. Ahmad M J Postgrad Med; 2006; 52(4):296-7. PubMed ID: 17102551 [TBL] [Abstract][Full Text] [Related]
51. Abacavir and increased risk of myocardial infarction. Edwards R; Bate A; Lindquist M Lancet; 2008 Sep; 372(9641):805. PubMed ID: 18774415 [No Abstract] [Full Text] [Related]
52. Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone. Moyle GJ AIDS Read; 2003 Nov; 13(11):528, 533-5. PubMed ID: 14649622 [No Abstract] [Full Text] [Related]
53. Abacavir and lamivudine combination. Somboonwit C; Kurtyka D; Velez AP Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1599-606. PubMed ID: 19929448 [TBL] [Abstract][Full Text] [Related]
54. Glaxo opens broad expanded access program for abacavir (Ziagen). Baker R BETA; 1998 Apr; ():6. PubMed ID: 11365271 [TBL] [Abstract][Full Text] [Related]
55. More on abacavir-induced neuropsychiatric reactions. Foster R; Taylor C; Everall IP AIDS; 2004 Dec; 18(18):2449. PubMed ID: 15622330 [No Abstract] [Full Text] [Related]
57. Differential adipose tissue gene expression profiles in abacavir treated patients that may contribute to the understanding of cardiovascular risk: a microarray study. Shahmanesh M; Phillips K; Boothby M; Tomlinson JW PLoS One; 2015; 10(1):e0117164. PubMed ID: 25617630 [TBL] [Abstract][Full Text] [Related]
58. Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled? Fichtenbaum CJ; Mallon P AIDS; 2023 Mar; 37(3):541-543. PubMed ID: 36695364 [No Abstract] [Full Text] [Related]
59. Hypersensitivity reactions due to abacavir. Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446 [TBL] [Abstract][Full Text] [Related]